Best in Biotech 28 Feb 2025
Rare Disease Day: seven drugs awaiting approval in 2025
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in 2025.
- Latest Posts
Podcast 28 Feb 2025
The TCR-T cell therapies of tomorrow
Sweden’s fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic cancer, with TCR-T cell therapy trials.
Best in Biotech 27 Feb 2025
Eight respiratory disease companies advancing innovative therapies in 2025
Discover eight respiratory disease companies advancing their novel therapies through clinical trials in 2025.
In Depth 26 Feb 2025
New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis?
Find out how biotechs are fighting pain with new non-opioid pain medication, as they look to overcome the ongoing opioid crisis.
Best in Biotech 25 Feb 2025
Seven biotech spinouts to watch out for in 2025
Here are seven biotech spinouts to keep an eye out for this year that specialize in a number of therapeutic areas.
How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases
Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 24 Feb 2025
Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?
This year has seen Eli Lilly sign several licensing deals to bolster its position across a range of therapeutic areas amid growing drug revenues.
In Depth 21 Feb 2025
The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Discover how biotech could solve the organ shortage crisis through xenotransplantation, 3D bioprinting and stem cells.
Podcast 21 Feb 2025
Can RNA drugs solve the obesity epidemic?
This week, we have a conversation with Alessandro Toniolo, CEO of Resalis Therapeutics, about a non-coding RNA drug candidate that promotes sustainable weight loss.
Best in Biotech 20 Feb 2025
3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder
Discover three promising approaches being investigated to treat Hunter syndrome, a rare genetic disorder affecting children.
News and Trends 19 Feb 2025
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry?
In Depth 18 Feb 2025
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer.
ADVERTISEMENT
